Search results
Found 6801 matches for
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
Oxford Medicine December 2020
Oxford Medicine December 2020
Oxford Medicine Spring Summer 2021
Oxford Medicine Spring Summer 2021
Oxford Medicine Summer 2022
Oxford Medicine Summer 2022
Oxford Medicine Magazine - Winter 2023
Oxford Medicine Magazine - Winter 2023
Oxford Medicine Autumn Winter 2021
Oxford Medicine Autumn Winter 2021